>

Resources

Find all the important information about our industry and plasma donation here. You will find high-value, reliable articles filled with interesting facts and thoughts.

Search material

Quick links

Member links

International Quality Plasma Program (IQPP)

International Quality Plasma Program (IQPP)

Quality Standards of Excellence, Assurance and Leadership (QSEAL)

Quality Standards of Excellence, Assurance and Leadership (QSEAL)

A missed opportunity to acknowledge EU’s dependency on U.S. plasma

A missed opportunity to acknowledge EU’s dependency on U.S. plasma

International Plasma Awareness Week 2022: Donate Locally. Think Globally.

International Plasma Awareness Week 2022: Donate Locally. Think Globally.

Patients links

North America Data program

North America Data program

Immunoglobulin Access Materials

Immunoglobulin Access Materials

Patient Notification System (PNS)

Patient Notification System (PNS)

Other links

THE SOURCE: Spring 2025

THE SOURCE: Spring 2025

Pathogen Safety

Pathogen Safety

PPTA Donor History Questionnaire

PPTA Donor History Questionnaire

National Donor Deferral Registry (NDDR®)

National Donor Deferral Registry (NDDR®)

Categories

Publications & Presentations

Discover the main highlights of our industry in our latest publications.

News & Press Releases

Stay up to date with the Association’s news and events.

Advocacy

Learn more about the Association's advocacy efforts to ensure patient access to therapies.

Access to Care

Discover a complete record of access to care issues by region and PPTA activities in support of access to therapies.

Safety & Quality

Learn more about the regulatory policies and the Association’s voluntary standards for safety & quality standards.

Plasma Collection & Manufacturing

Learn more about plasma collection and discover certified plasma centers near you.

Annual Reports

Read annual reports from past years.

The Source Magazine

Subscribe to the international magazine of the plasma protein therapeutics industry.

Plasma FAQS

Get answers about plasma therapies and the processes surrounding donation and collection procedures.

Plasma Therapies

Learn more about plasma protein therapies and their immense value to patients.

Fact Sheets

Fact sheets provide additional information about the global plasma protein therapeutics industry.

Patient Resources

Explore PPTA’s resources for patients interested in plasma protein therapies.

Blog Posts

A compilation of blog posts

Plasma Powers Possibility: How the Theme of IPAW Continues Year-Round as Donors Turn Science into Hope

Plasma Powers Possibility: How the Theme of IPAW Continues Year-Round as Donors Turn Science into Hope

Plasma Powers Possibility: How the Theme of IPAW Continues Year-Round as Donors Turn Science into Hope

Plasma Powers Possibility: How the Theme of IPAW Continues Year-Round as Donors Turn Science into Hope

Voices of Hope: Patients Share the Power of Plasma Donations

Voices of Hope: Patients Share the Power of Plasma Donations

Voices of Hope: Patients Share the Power of Plasma Donations

Voices of Hope: Patients Share the Power of Plasma Donations

Plasma Powers Possibility: IPAW 2025 Brings Global Attention to Plasma Donation and Patient Access

Plasma Powers Possibility: IPAW 2025 Brings Global Attention to Plasma Donation and Patient Access

Plasma Powers Possibility: IPAW 2025 Brings Global Attention to Plasma Donation and Patient Access

Plasma Powers Possibility: IPAW 2025 Brings Global Attention to Plasma Donation and Patient Access

Ensuring Patient Access and Open Strategic Autonomy in Europe: PPTA’s Recommendations for the Critical Medicines Act

Plasma Protein Therapeutics Association (PPTA) calls on policymakers to ensure that the Critical Medicines Act includes tailored provisions that address the unique characteristics of plasma-derived medicinal products (PDMPs).

Ensuring Patient Access and Open Strategic Autonomy in Europe: PPTA’s Recommendations for the Critical Medicines Act

https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/690ca87c90ae197ef4110192_Ensuring%20Patient%20Access%20and%20Open%20Strategic%20Autonomy%20in%20Europe_PPTA%20CMA%20Recommendations.pdf

Ensuring Patient Access and Open Strategic Autonomy in Europe: PPTA’s Recommendations for the Critical Medicines Act

Plasma Protein Therapeutics Association (PPTA) calls on policymakers to ensure that the Critical Medicines Act includes tailored provisions that address the unique characteristics of plasma-derived medicinal products (PDMPs).

Ensuring Patient Access and Open Strategic Autonomy in Europe: PPTA’s Recommendations for the Critical Medicines Act

https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/690ca87c90ae197ef4110192_Ensuring%20Patient%20Access%20and%20Open%20Strategic%20Autonomy%20in%20Europe_PPTA%20CMA%20Recommendations.pdf

No results found